Literature DB >> 25560255

NADf chip, a two-color microarray for simultaneous screening of multigene mutations associated with hearing impairment in North African Mediterranean countries.

Imen Chakchouk1, Mariem Ben Said1, Fida Jbeli1, Riadh Benmarzoug1, Salma Loukil1, Ibtihel Smeti1, Amine Chakroun2, Abdullah Ahmed Gibriel3, Abdelmonem Ghorbel2, Hassen Hadjkacem1, Saber Masmoudi4.   

Abstract

Hearing impairment (HI) is the most frequent sensory defect. Genetic causes are involved in two thirds of prelingual cases. Moreover, the autosomal recessive HI frequency is increased in countries where there is a high rate of consanguinity, such as in North African Mediterranean countries. This population shares several features, including history and social behavior, that promote the spread of founder mutations. HI is characterized by tremendous heterogeneity in both the genetic and clinical aspects. The identification of the causal mutation is important for early diagnosis, clinical follow-up, and genetic counseling. Addressing the extreme genetic heterogeneity of HI using classic molecular methods would be expensive and time-consuming. We designed a cost-effective North African Deafness chip for rapid and simultaneous analysis of 58 mutations using multiplex PCR coupled with dual-color arrayed primer extension. These mutations are found in North African HI patients and are distributed over 31 exons and five introns in 21 distinct genes. Assay specificity was initially optimized using 103 archived DNA samples of known genotypes. Blind validation of HI-unrelated patients revealed mutant alleles in 13 samples, and these mutations were confirmed by Sanger sequencing. The North African Deafness chip allows for simultaneous genotyping of eight different samples, at a minimal cost and in a single day, and is therefore amenable to large-scale molecular screening of HI in North Africa.
Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25560255     DOI: 10.1016/j.jmoldx.2014.11.003

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  13 in total

1.  Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53.

Authors:  Imen Chakchouk; M'hamed Grati; Guney Bademci; Mariem Bensaid; Qi Ma; Amine Chakroun; Joseph Foster; Denise Yan; Duygu Duman; Oscar Diaz-Horta; Abdelmonem Ghorbel; Rahul Mittal; Amjad Farooq; Mustafa Tekin; Saber Masmoudi; Xue Zhong Liu
Journal:  Mol Genet Genomics       Date:  2015-01-30       Impact factor: 3.291

2.  Analysis of p.Gly12Valfs*2, p.Trp24* and p.Trp77Arg mutations in GJB2 and p.Arg81Gln variant in LRTOMT among non syndromic hearing loss Egyptian patients: implications for genetic diagnosis.

Authors:  Abdullah A Gibriel; Maha H Abou-Elew; Saber Masmoudi
Journal:  Mol Biol Rep       Date:  2019-02-07       Impact factor: 2.316

3.  A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60.

Authors:  Mariem Ben Said; M'hamed Grati; Takahiro Ishimoto; Bing Zou; Imen Chakchouk; Qi Ma; Qi Yao; Bouthaina Hammami; Denise Yan; Rahul Mittal; Noritaka Nakamichi; Abdelmonem Ghorbel; Lingling Neng; Mustafa Tekin; Xiao Rui Shi; Yukio Kato; Saber Masmoudi; Zhongmin Lu; Mounira Hmani; Xuezhong Liu
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

4.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

Review 5.  Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications.

Authors:  Abdullah A Gibriel; Ola Adel
Journal:  Mutat Res Rev Mutat Res       Date:  2017-05-02       Impact factor: 5.657

6.  SLC22A4 Gene in Hereditary Non-syndromic Hearing Loss: Recurrence and Incomplete Penetrance of the p.C113Y Mutation in Northwest Africa.

Authors:  Chiara Chiereghin; Michela Robusto; Lucia Mauri; Paola Primignani; Pierangela Castorina; Umberto Ambrosetti; Stefano Duga; Rosanna Asselta; Giulia Soldà
Journal:  Front Genet       Date:  2021-02-10       Impact factor: 4.599

Review 7.  Genetics and meta-analysis of recessive non-syndromic hearing impairment and Usher syndrome in Maghreb population: lessons from the past, contemporary actualities and future challenges.

Authors:  Amal Souissi; Abdullah A Gibriel; Saber Masmoudi
Journal:  Hum Genet       Date:  2021-07-15       Impact factor: 4.132

8.  Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in Tunisian population.

Authors:  Amal Souissi; Mariem Ben Said; Ikhlas Ben Ayed; Ines Elloumi; Amal Bouzid; Mohamed Ali Mosrati; Mehdi Hasnaoui; Malek Belcadhi; Nabil Idriss; Hassen Kamoun; Nourhene Gharbi; Abdullah A Gibriel; Abdelaziz Tlili; Saber Masmoudi
Journal:  J Adv Res       Date:  2021-01-12       Impact factor: 10.479

9.  Genetic analysis of Tunisian families with Usher syndrome type 1: toward improving early molecular diagnosis.

Authors:  Imen Ben-Rebeh; Mhamed Grati; Crystel Bonnet; Walid Bouassida; Imen Hadjamor; Hammadi Ayadi; Abdelmonem Ghorbel; Christine Petit; Saber Masmoudi
Journal:  Mol Vis       Date:  2016-07-19       Impact factor: 2.367

10.  A novel pathogenic variant in the LRTOMT gene causes autosomal recessive non-syndromic hearing loss in an Iranian family.

Authors:  Akram Sarmadi; Samane Nasrniya; Maryam Soleimani Farsani; Sina Narrei; Zahra Nouri; Mahsa Sepehrnejad; Mohammad Hussein Nilforoush; Hamidreza Abtahi; Mohammad Amin Tabatabaiefar
Journal:  BMC Med Genet       Date:  2020-06-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.